Get informed when a big investor buys or sells
+ FollowOvervalued by 229.4% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $4.29 Million |
|---|---|
| Enterprise Value | $5.79 Million |
| Earnings per Share | $0 |
| Beta | 0.88 |
| Outstanding Shares | 2,523,096,680 |
| P/E Ratio | -3.56 |
|---|---|
| PEG | 106.99 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 71.56 |
| Enterprise Value to EBIT | -4.57 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.26 |
| Debt to Equity | -0.08 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Univec, Inc. is a medical device firm that, through its various operating divisions, develops, licenses, and sells products across the United States and internationally. Its primary offerings include a range of auto-disable and safety sy...